Pharmaceutical Statistics

Table of Contents

Pharmaceutical Statistics - Early View Articles

${pageCtx.sharedData.issuePages}

MAIN PAPERS

Applications of Bayesian analysis to proof‐of‐concept trial planning and decision making

  • Author: Hui Quan, Xun Chen, Yu Lan, Xiaodong Luo, Rene Kubiak, Nicolas Bonnet, Gautier Paux
  • Pub Online: Jan 07, 2020
  • DOI: 10.1002/pst.1985 (p )

A resampling‐based test for two crossing survival curves

  • Author: Tiantian Liu, Marc Ditzhaus, Jin Xu
  • Pub Online: Jan 09, 2020
  • DOI: 10.1002/pst.2000 (p )

What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD

  • Author: Oliver N. Keene, Stephen Ruberg, Alexander Schacht, Mouna Akacha, Rachael Lawrance, Anna Berglind, David Wright
  • Pub Online: Jan 10, 2020
  • DOI: 10.1002/pst.1986 (p )

On evaluating how well a biomarker can predict treatment response with survival data

  • Author: Bassirou Mboup, Paul Blanche, Aurélien Latouche
  • Pub Online: Jan 13, 2020
  • DOI: 10.1002/pst.2002 (p )

A novel quantification of information for longitudinal data analyzed by mixed‐effects modeling

  • Author: Min Yuan, Yi Li, Yaning Yang, Jinfeng Xu, Fangbiao Tao, Liang Zhao, Honghui Zhou, Jose Pinheiro, Xu Steven Xu
  • Pub Online: Jan 28, 2020
  • DOI: 10.1002/pst.1996 (p )

START: single‐to‐double arm transition design for phase II clinical trials

  • Author: Haolun Shi, Teng Zhang, Guosheng Yin
  • Pub Online: Feb 15, 2020
  • DOI: 10.1002/pst.2005 (p )

Restricted mean survival time as a summary measure of time‐to‐event outcome

  • Author: Takahiro Hasegawa, Saori Misawa, Shintaro Nakagawa, Shinichi Tanaka, Takanori Tanase, Hiroyuki Ugai, Akira Wakana, Yasuhide Yodo, Satoru Tsuchiya, Hideki Suganami
  • Pub Online: Feb 19, 2020
  • DOI: 10.1002/pst.2004 (p )

Designing cancer immunotherapy trials with delayed treatment effect using maximin efficiency robust statistics

  • Author: Jianrong Wu, Xue Ding
  • Pub Online: Feb 24, 2020
  • DOI: 10.1002/pst.2003 (p )

Estimation of group means using Bayesian generalized linear mixed models

  • Author: Amy LaLonde, Yongming Qu
  • Pub Online: Feb 28, 2020
  • DOI: 10.1002/pst.2006 (p )

Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasis

  • Author: Daniel Saure, Alexander Schacht, Zbigniew Kadziola, Alan J. M. Brnabic
  • Pub Online: Mar 02, 2020
  • DOI: 10.1002/pst.2011 (p )

Letters to the Editor

Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18 (2):239‐47, 2019, DOI: 10.1002/pst.1920

  • Author: Steven D. Edland, Nandini Raghavan, M. Colin Ard
  • Pub Online: Mar 09, 2020
  • DOI: 10.1002/pst.2007 (p )

MAIN PAPERS

Revisit of test‐then‐pool methods and some practical considerations

  • Author: Duane Snavely, Frank Liu, Wen Li
  • Pub Online: Mar 14, 2020
  • DOI: 10.1002/pst.2009 (p )

Commentaries

MAIN PAPERS

Comparison of response adaptive randomization features in multiarm clinical trials with control

  • Author: Kristine Broglio, Anna McGlothlin, Benjamin R. Saville, Kert Viele
  • Pub Online: Mar 21, 2020
  • DOI: 10.1002/pst.2015 (p )
Page:   1 2 3 4 Next

Related Topics

Related Publications

Related Content

Site Footer

Address:

This website is provided by John Wiley & Sons Limited, The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ (Company No: 00641132, VAT No: 376766987)

Published features on StatisticsViews.com are checked for statistical accuracy by a panel from the European Network for Business and Industrial Statistics (ENBIS)   to whom Wiley and StatisticsViews.com express their gratitude. This panel are: Ron Kenett, David Steinberg, Shirley Coleman, Irena Ograjenšek, Fabrizio Ruggeri, Rainer Göb, Philippe Castagliola, Xavier Tort-Martorell, Bart De Ketelaere, Antonio Pievatolo, Martina Vandebroek, Lance Mitchell, Gilbert Saporta, Helmut Waldl and Stelios Psarakis.